KOOL - Cesca Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 518.72M
Enterprise Value 312.46M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.56
Price/Book (mrq)0.50
Enterprise Value/Revenue 31.04
Enterprise Value/EBITDA 6-1.53

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin -37.97%
Operating Margin (ttm)-73.01%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)12.03M
Revenue Per Share (ttm)1.19
Quarterly Revenue Growth (yoy)-26.50%
Gross Profit (ttm)5.84M
EBITDA -8.14M
Net Income Avi to Common (ttm)-4.57M
Diluted EPS (ttm)-0.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.51M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)N/A
Total Debt/Equity (mrq)20.17
Current Ratio (mrq)N/A
Book Value Per Share (mrq)3.29

Cash Flow Statement

Operating Cash Flow (ttm)-6.63M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta 0.48
52-Week Change 3-42.39%
S&P500 52-Week Change 313.44%
52 Week High 36.44
52 Week Low 31.45
50-Day Moving Average 32.26
200-Day Moving Average 33.02

Share Statistics

Avg Vol (3 month) 380.92k
Avg Vol (10 day) 3104.3k
Shares Outstanding 511.48M
Float N/A
% Held by Insiders 163.81%
% Held by Institutions 111.04%
Shares Short 3187.43k
Short Ratio 36.96
Short % of Float 36.07%
Shares Short (prior month) 3197.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/20
Last Split Date 3Mar 7, 2016